OrbiMed Investor

OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private startups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds. From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide. OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and royalty opportunities.
Technology: Drug Design
Industry: Precision Medicine
Headquarters: New York, New York, United States
Founded Date: 1989
Employees Number: undisclosed
Funding Status: undisclosed
Investor Type: Private Equity Firm
Investment Stage: Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity
Number Of Exits: 115

Visit Website
info@orbimed.com
https://twitter.com/OrbiMed
Register and Claim Ownership